Pharmaceutical Industry Trends & News - Pharmaceutical Technology

News

EU sees 2025 pharma export uptick amid competitiveness concerns

An analyst noted that this uptick may be a case of “frontloading”, meaning the EU’s 2026 export growth outlook may not be as strong.

Annabel Kartal Allen

News

Novo Nordisk and OpenAI forge alliance to drive speedy drug development

Annabel Kartal Allen

News

Travere Therapeutics gains FDA approval for sparsentan in FSGS

Salong Debbarma

News

Pharma 5.0, Sustainability & Security: PHARMAP 2026 brings pharma’s future into focus

News

Telix and Regeneron sign $4.3bn deal to co-develop radiopharmaceutical therapies

News

AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid

News

MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority

News

FDA issues complete response letter to Replimune’s RP1 for melanoma

Analysis

Analyst Comment

Emerging therapies bring hope for frail HNSCC patients unfit for standard treatment

GlobalData Healthcare

Comment

Advancing single-cell transcriptomics into the mainstream of biomedical research

Analyst Comment

In the face of tariffs, FDA-approved drug manufacturing deals are shifting to Europe

GlobalData Healthcare

Analyst Comment

HNSCC market is expected to reach to $4.5bn across 8MM by 2034

GlobalData Healthcare

Themes

Partner Content

CinnaGen Enters EU Market with EMA Approval for Zandoriah®

CinnaGen today announced that the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Zandoriah® (teriparatide),…

More themes

News

Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer

Partner Content

Huawei’s three key steps to drive industrial intelligence forward and unleash AI’s full potential

Analyst Comment

First responders see AI and other advanced tech as essential

Features

What does the EU Data Act mean for businesses?

Data Insights

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...

Data Insights

Leading clinical trials companies in the artificial intelligence theme

Data Insights

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

Data Insights

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

More Insights

Buyer's Guides

Buyer's Guides

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Buyer's Guides

Leading artificial intelligence (AI) companies in pharma

Buyer's Guides

Leading strategic intelligence solutions for the pharmaceutical industry

Buyer's Guides

Key lead generation providers and technology solutions for the pharmaceutical industry

GlobalData Reports

Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape

$3495.00

Bio/Pharmaceutical Outsourcing Report, March 2026

$2950.00

Human Immunodeficiency Virus (HIV) Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

$17995.00

Diffuse Large B-Cell Lymphoma - Global Clinical Trials Review, 2026

$3450.00

Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2026

$3450.00

Digital Magazine

Latest Issue

Pharma Technology Focus

Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.

Sections

Sections

Sections

Sections

Sections

Sections

Novo Nordisk and OpenAI forge alliance to drive speedy drug development

Travere Therapeutics gains FDA approval for sparsentan in FSGS

Pharma 5.0, Sustainability & Security: PHARMAP 2026 brings pharma’s future into focus

Telix and Regeneron sign $4.3bn deal to co-develop radiopharmaceutical therapies

AbbVie bets on Chinese biopharma’s pain pipeline in $745m bid

MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority

FDA issues complete response letter to Replimune’s RP1 for melanoma

Emerging therapies bring hope for frail HNSCC patients unfit for standard treatment

Advancing single-cell transcriptomics into the mainstream of biomedical research

In the face of tariffs, FDA-approved drug manufacturing deals are shifting to Europe

HNSCC market is expected to reach to $4.5bn across 8MM by 2034

CinnaGen Enters EU Market with EMA Approval for Zandoriah®

Cell & gene therapy: the leading companies in recombinant AAV gene therapy revealed

Accelerate decision-making with data-led confidence

Leading clinical trials companies in the artificial intelligence theme

Private equity deals in pharmaceutical in Canada remained flat in Q3 2024

BNT-325 by BioNTech for Malignant Mesothelioma: Likelihood of Approval

Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry

Leading artificial intelligence (AI) companies in pharma

Leading strategic intelligence solutions for the pharmaceutical industry

Key lead generation providers and technology solutions for the pharmaceutical industry

Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape

Bio/Pharmaceutical Outsourcing Report, March 2026

Human Immunodeficiency Virus (HIV) Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

Diffuse Large B-Cell Lymphoma - Global Clinical Trials Review, 2026

Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

Sign up for our daily news round-up!

Give your business an edge with our leading industry insights.

More themes

Accelerate decision-making with data-led confidence

More Insights

Thyroid Cancer (TC): Market View, Current and Future Competitive Landscape

Bio/Pharmaceutical Outsourcing Report, March 2026

Human Immunodeficiency Virus (HIV) Major Markets: Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2033

Diffuse Large B-Cell Lymphoma - Global Clinical Trials Review, 2026

Muscle Invasive Bladder Cancer (MIBC) - Global Clinical Trials Review, 2026

Pharma Technology Focus

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Thank you for subscribing